2011
Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions
Beletsky L, Grau LE, White E, Bowman S, Heimer R. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions. Drug And Alcohol Dependence 2011, 119: 145-149. PMID: 21705159, PMCID: PMC3192926, DOI: 10.1016/j.drugalcdep.2011.05.034.Peer-Reviewed Original ResearchConceptsSyringe exchange programsInjection drug usersNeedle stick injuriesCommunity-based prevention initiativesPublic health benefitsStick injuriesHIV transmissionPublic health rationaleDrug usersMost program managersMultivariate analysisSyringe possessionPrevention initiativesEvidence baseHealth benefitsCommunity healthOccupational healthHealth rationaleMultivariate modelingPrevalenceStructural interventionsSEP operationsPredictorsHealthPrevious year
2010
The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs
Beletsky L, Grau LE, White E, Bowman S, Heimer R. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs. Addiction 2010, 106: 357-365. PMID: 21054615, PMCID: PMC3088513, DOI: 10.1111/j.1360-0443.2010.03149.x.Peer-Reviewed Original ResearchSurvival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users. The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersDrug usersC virusHigh prevalenceInsulin syringesViable virusTuberculin syringesHCV infectivityResidual volumeReporter virusDay 1Prevention strategiesDay 7Microculture assayDay 63VirusLuciferase activitySyringesDegrees CPrevalenceVirus survivalSurvivalVirus decay ratesDays
2009
Statistical design for a small serial dilution series
Zelterman D, Tulupyev A, Heimer R, Abdala N. Statistical design for a small serial dilution series. Statistics In Medicine 2009, 29: 411-420. PMID: 19943329, PMCID: PMC3113538, DOI: 10.1002/sim.3774.Peer-Reviewed Original ResearchMeSH KeywordsBlood-Borne PathogensHIVHumansModels, StatisticalResearch DesignSyringesViral LoadVirion
2008
Community coverage and HIV prevention: Assessing metrics for estimating HIV incidence through syringe exchange
Heimer R. Community coverage and HIV prevention: Assessing metrics for estimating HIV incidence through syringe exchange. International Journal Of Drug Policy 2008, 19: 65-73. PMID: 18207726, PMCID: PMC2367433, DOI: 10.1016/j.drugpo.2007.12.004.Peer-Reviewed Original Research
2001
Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-1Undiluted bleachDrug usersHIV-1 recoveryViable HIV-1HIV-1 transmissionHarm reduction interventionsEffectiveness of bleachNeedle exchangeReduction interventionsMicroculture assaySingle rinseSterile syringeSyringesInjection behaviorEducational programsMinimal contact time
2000
Viability of HIV-1 in syringes: implications for interventions among injection drug users.
Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.Peer-Reviewed Original ResearchSurvival of HIV-1 in Syringes: Effects of Temperature during Storage
Abdala N, Reyes R, Carney J, Heimer R. Survival of HIV-1 in Syringes: Effects of Temperature during Storage. Substance Use & Misuse 2000, 35: 1369-1383. PMID: 10921429, DOI: 10.3109/10826080009148220.Peer-Reviewed Original Research
1999
HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1
Clatts M, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson K, Gallo T, Hoffer L, Luciano P, Kyriakides T. HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 194-199. PMID: 10843535, DOI: 10.1097/00126334-199910010-00013.Peer-Reviewed Original ResearchSurvival of HIV-1 in Syringes
Abdala N, Stephens C, Griffith B, Heimer R. Survival of HIV-1 in Syringes. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 73-80. PMID: 9928733, DOI: 10.1097/00042560-199901010-00011.Peer-Reviewed Original Research
1998
Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection
Rich J, Dickinson B, Carney J, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998, 12: 2345-2350. PMID: 9863878, DOI: 10.1097/00002030-199817000-00017.Peer-Reviewed Original ResearchCan Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?
Heimer R. Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment? Journal Of Substance Use And Addiction Treatment 1998, 15: 183-191. PMID: 9633030, DOI: 10.1016/s0740-5472(97)00220-1.Peer-Reviewed Original ResearchSyringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities
Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s37-s44. PMID: 9663622, DOI: 10.1097/00042560-199802001-00008.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluationHIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniques
Myers S, Heimer R, Liu D, Henrard D. HIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniques. AIDS 1993, 7: 925-932. PMID: 8357554, DOI: 10.1097/00002030-199307000-00004.Peer-Reviewed Original Research
1992
Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program
Heimer R, Kaplan E, Cadman E. Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program. New England Journal Of Medicine 1992, 327: 1883-1884. PMID: 1448131, DOI: 10.1056/nejm199212243272613.Peer-Reviewed Original Research